Table 3.
Responses of newly diagnosed and relapsed/refractory NHL groups.
Newly diagnosed
Relapsed and refractory
P
Evaluable (
n
)
17
15
-
CR (%)
76.5
40
> 0.05
OR (%)
94.1
53.3
0.01 <
P
< 0.05